Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II/III trial to study the effectiveness of combination chemotherapy in
treating children with relapsed acute lymphocytic leukemia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Grupo Argentino de Tratamiento de la Leucemia Aguda